|
|
|
|
|
|
|
|
Medpage Today
Primary Source
-
San Antonio Breast Cancer Symposium
Multiple genes were recurrently altered in these tumors at significantly higher rates than in ER+ primary breast cancer. When compared with matched primary tumors from the same patient, alterations in these and other genes were often found to be acquired after treatment....
Cohen O, et al "Whole exome and transcriptome sequencing of resistant ER+ metastatic breast cancer" SABCS 2016; Abstract S1-01.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.